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Abstract
Background and Objectives: In our study we aimed to investigate the effect of bupivacaine 
and levobupivacaine on QT, corrected QT (QTc), and P wave dispersion durations during spinal 
anesthesia in cesarean section. 
Methods: Sixty parturients scheduled for elective cesarean section in ASA I-II risk groups were 
included in the study. Baseline electrocardiographic  (ECG) records of the patients were obtained 
in the operation room. Heart rate (HR), non-invasive blood pressure (NIBP), peripheral oxygen 
saturation (SpO2) and respiration rates (RR) were recorded. Venous cannulation was performed 
with 18G cannula and ﬂ uid preload made with 10 mL.kg-1. Lactated Ringer solution. After ﬂ uid 
preload, second ECG recordings were taken and the patients were randomly separated into two 
groups. Group B (n = 30) received 10 mg of bupivacaine and Group L (n = 30) received 10 mg 
of levobupivacaine for spinal anesthesia. ECG recordings were repeated at 1, 5 and 10 minutes 
after spinal block. HR, NIBP, SpO2 , RR and sensory block levels were also recorded at the same 
time intervals. At predetermined time intervals of spinal anesthesia, P wave dispersion (Pwd), 
QT dispersion (QTd), and QTc dispersion (QTcd) durations were measured from ECG records. QT 
and QTc durations are calculated with Bazzett formula.
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Results: There was no difference between two groups according to block levels, hemodynamic 
parameters, Pwd, QTd, QTc and QTcd durations. 
Conclusion: Bupivacaine and levobupivacaine may be preferred in spinal anesthesia in pregnant 
patients who have extended Pwd and QTcd preoperatively. 
© 2013 Sociedade Brasileira de Anestesiologia. Published by Elsevier Editora Ltda. 
Introduction 
Anesthetic agents may display proarrhythmic and antiarrhyth-
mic activity by inducing electrical activity with various 
mechanisms 1. Other than the anesthetic agents used, exist-
ing heart disease and other concomitant systemic diseases, 
surgical manipulation, procedures performed on the patient 
and medication may also cause arrhythmias in the intraop-
erative stage 2. Many hormonal and hemodynamic changes 
that take place during pregnancy may also result in proar-
rhythmic effects. Pregnancy may trigger the development 
of new arrhythmia or exacerbate already existing ones. Left 
axis deviation may be present in ECG as a result of the shift 
in the position of the heart due to the enlargement of the 
uterus during pregnancy. Premature atrial and ventricular 
beats are common 3. 
Regional anesthesia in cesarean surgeries has the advan-
tages of allowing the mother to be awake during delivery, 
not neeeding airway manipulation, keeping mother’s airway 
reﬂ exes, decreasing blood loss, reducing the risk of drug-
induced fetal depression, and carrying the need for analgesia 
over to the postoperative stage. Regional anesthesia is the 
most common method of anesthesia used in cesarean surger-
ies in developed countries 4-6. One of the most commonly used 
local anesthetics in obstetrics is bupivacaine. A relatively 
new agent, levobupivacaine is also increasingly being used 
in obstetric patients 7. Bupivacaine and levobupivacaine may 
increase the PR interval and QRS duration and prolong cardiac 
conduction 8. Bupivacaine in spinal anesthesia had been re-
ported to induce ECG changes 9,10. However, levobupivacaine 
has been shown to be less cardiotoxic 11. On the other hand, 
high sympathetic blockage and hemodynamic changes that 
occur due to regional anesthesia and the inotropic agents 
used may cause proarrhythmic effects 10. However, this has 
not been investigated adequately through research.
In our study, we aimed to examine the effects of bupi-
vacaine and levobupivacaine on QT, QTc and P wave disper-
sion in pregnant women.
Material and Method
This prospective randomized study was conducted in 2009-
2010 at Zonguldak Karaelmas University’s School of Medicine 
Research and Practice Hospital, Department of Anesthesiology 
and Reanimation, after obtaining the approval of the Hospital 
Ethics Board (06. 12. 2007, Meeting decision No.: 2007 /09 
/04) and patient consents.
Sixty pregnant women aged between 16 and 50, 
height ≥ 1.60 cm, weight between 60 and 100 kg, placed in 
the ASA risk group I-II in their preanesthetic evaluation and 
scheduled for elective cesarean surgery were included in 
the study. They were randomly allocated into two groups: 
bupivacaine (Group B) and levobupivacaine (Group L) by 
using a randomized numbers table.
Exclusion criteria were refusal to participate in the 
study, the existence of brain tumors, scalded skin syndrome 
(SSS infection), spinal cord and peripheral nervous system 
diseases (poliomyelitis, multiple sclerosis, demyelinating 
diseases), hemorrhagic and hypovolemic shock, severe 
anemia, increased intracranial pressure, aortic and valvular 
heart disease, cardiac decompensation, systemic infection 
(generalized sepsis and bacteremia), local infection (dermal 
infections in puncture site of spinal needle, etc.), congenital 
spinal anomalies, scoliosis, post-traumatic vertebral injuries, 
vertebral colon metastatic lesions, increased abdominal 
pressure, chronic severe headache, anticoagulant drug use 
and anatomic difﬁ culties, electrolyte disturbances diabetes 
mellitus, hypothyroidism, hyperthyroidism, cardiomyopathy, 
atrial and/or ventricular hypertrophy on ECG, cardiomegaly, 
valvular disease, cardiac failure or chronic disease, patients 
with excessive smoking and alcohol consumption and used 
medication causing QT interval prolongation.
Premedication was not administered to our subjects. 
Following their admission into the operation room, ECG 
monitorization was performed and their control ECG (T0) 
records were taken. Heart rate, noninvasive blood pressure, 
peripheral oxygen saturation values and respiration rates 
were recorded. 
Vascular access was obtained by using 18G catheter. 
Preloading was performed with a 10 mL.kg-1 Lactated Ringer’s 
solution. Following the preloading, second ECG (T1) records 
were taken and the patients were placed in lateral decubitus 
position. Dural puncture was performed from the L2-L3 or 
L3-L4 interval by using a 27G quincke spinal needle. After 
the ﬂ ow of cerebrospinal ﬂ uid we administered 10 mg bupi-
vacaine in Group B (n = 30) and 10 mg levobupivacaine in 
Group L (n = 30) in two minutes (at a speed of 1.5 mL.min-1) 
intrathecal. We brought patients to a supine position after 
the injection. 
Other ECG records were taken 1 (T2), 5 (T3), and 10 (T4) 
minutes after the block. Bromage scale (BS) scores, heart 
rate, blood pressure, peripheral oxygen saturation, respira-
tion rate values and sensory block levels with pinprick test 
were recorded at minutes 1, 5 and 10 of spinal anesthesia 
and every 5 minutes thereafter.
Additional ﬂ uid loading and stabilization of hemodynam-
ics with 5 mg ephedrine was planned for cases where blood 
pressure values fell 20% below control values; 0.5 mg IV 
atropine was planned for cases where heart rate fell below 
55 beats.min-1; and 10 mg IV metoclopramide was planned for 
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patients with nausea and vomiting. Standard 2 L.min-1 oxygen 
was delivered to all patients via nasal cannula. Sensory and 
motor block levels were identiﬁ ed and noted until 10 min 
and surgery started later. 
Electrocardiography
Standard 12 derivation ECG recordings obtained with a pa-
per speed of 25 mm.sec-1 and a deﬂ ection of 10 mm.mV-1 of 
patients participating in the study was analyzed (Hewlett 
Packard®, Pagewriter 300pı). We calculated heart rate using 
mean RR time. 
Analysis of QT dispersion
The QT interval was deﬁ ned as between the beginning of 
QRS complex and the point where T waves descend onto the 
TP isoelectric line. When a U wave interrupted the T wave 
before returning to baseline, the QT interval was measured 
to the nadir of the curve between the T and U waves 1. The 
corrected QT interval (QTc) was calculated using the Bazett 
formula; QTc (ms) = QT measured/√RR (where RR is the RR 
interval). The QTd value was determined as the difference 
between the longest and shortest QT intervals in the 12 ECG 
leads. The QTc dispersion (QTcd) duration according to heart 
rate was identiﬁ ed with the Bazett formula; QTcd (ms) = QTd 
measured/√RR 1.
Analysis of P-wave dispersion
The beginning of P-wave was deﬁ ned as positive deﬂ ection 
from the isoelectric line, and the end point when the posi-
tive deﬂ ection returned to the isoelectric line 1. Derivations 
where the beginning and end of P-waves were not obvious 
were excluded from the study. Pwd was the difference be-
tween the longest and shortest P-wave durations 1. 
Subjects who had less than 9 derivations assessed on the 
ECG were excluded from the study. All ECG measurements 
were evaluated three times by two experts who were not 
aware of which group the subject belonged to 1. 
Statistical Analysis
Statistical analyses were performed by using the Statistical 
Package for the Social Sciences (SPSS) 13.0 (SPSS Inc., 
Chicago, IL, USA). Descriptive statistics included arithmetic 
mean ± standard deviation for numerical data, and num-
bers and percentages for categorical data. We used the 
Kolmogorov-Smirnov test to examine compatibility between 
measured variables and normal distribution. We used a signiﬁ -
cance test when parametric test assumptions were met for 
intergroup differences between the measured variables, and 
the Mann-Whitney U test when they were not. We analyzed 
the differences between groups for categorical variables 
by using Chi-Square analysis. For measured variables, we 
analyzed differences between groups and time-dependent 
changes by two-way analysis of variance in repeated 
measurements. When we found a difference as a result of 
two-way analysis of variance in repeated measurements, 
comparisons between pairs were made with the Bonferroni 
test. For ordinary variables, differences between groups and 
time-dependent changes were analyzed by using analysis of 
variance in repeated measurements. The results were evalu-
ated at 95% conﬁ dence interval and p < 0.05 was accepted 
as statistically signiﬁ cant difference. 
Results
Our subjects were allocated randomly into two groups. 
Groups were similar in terms of age, body mass, height and 
American Society of Anesthesiologists risk class (Table 1). 
When we compared the groups with respect to sensory 
block levels, we found no statistically signiﬁ cant difference 
between groups at any time (p > 0.05) (Table 2).
Compared with respect to systolic and diastolic arterial 
blood pressure values at all times, Groups B and L did not 
display a statistically signiﬁ cant difference (p > 0.05). When 
we compared T3 and T4 times against control values, we 
saw a signiﬁ cant decrease in systolic and diastolic arterial 
blood pressure values in both Groups B and L (p < 0.05) 
(Table 3). When the mean heart rates in the two groups 
were compared, a statistically signiﬁ cant difference did 
not exist between or within groups at any time (p > 0.05) 
(Table 3). 
When the groups were compared with regard to maxi-
mum P-wave values, no statistically signiﬁ cant difference 
was found between the values measured in Groups B and 
L at any time (p = 0.146). When T4 time was compared 
with the control value, a signiﬁ cant decrease was detected 
in the maximum P-wave value of Group L (p = 0.015) 
(Table 3).  
Table 1  Demographic and anthropometric data of groups.
Group B (n = 30) Group L (n = 30) p
Age (year) 28.0 ± 5.34 26.8 ± 4.2 0.323
Weight (kg) 79.1 ± 11.35 77.07 ± 9.0 0.446
Height (cm) 163.4 ± 2.5 163.8 ± 3.2 0.531
n (%) n (%)
ASA
I 28 (%93.3) 26 (%80)
0.254II 2 (%6.7) 4 (%20)
ASA: American Society of Anesthesiologists.
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Table 2  Sensory block levels of groups.
Time Group B (n = 30) Group L (n = 30) p
   T0 – – –
   T1 – – –
   T2 L1 (Th10-5) L1 (Th11-L5) 0.150
   T3 Th8 (Th4- T12) Th8 (Th6-Th11) 0.106
   T4 Th4 (Th2-Th6) Th4 (Th3-Th5) 0.327
T0: Control, T1: After the preloading, T2: 1 minute after spinal anesthesia, T3: 5 minutes after spinal anesthesia, T4: 10 
minutes after spinal anesthesia.
Table 3  Hemodynamic and Electrocardiographic data of groups.
T0 T1 T2 T3 T4
HR (beats.min-1)
   Group B (n = 30) 90.6 ± 13.7 91.5 ± 15.9 95.6 ± 15.7 91.9 ± 21.6 96.0 ± 23.7
   Group L (n = 30) 90.6 ± 12.9 90.1 ± 13.3 92.2 ± 20.0 88.2 ± 17.8 87.6 ± 18.5
SAP (mm Hg)
   Group B (n = 30) 122.6 ± 13.5 128.7 ± 14.4 123.2 ± 15.2 104.6 ± 21.4* 110.4 ± 21.7*
   Group L (n = 30) 127.8 ± 9.1 131.5 ± 10.9 121.1 ± 15.3 111.4 ± 18.6† 113.1 ± 20.8†
DAP (mm Hg)
   Group B (n = 30) 75.1 ± 11.2 79.0 ± 9.2 72.9 ± 14.2 58.2 ± 16.1* 64.3 ± 15.1*
   Group L (n = 30) 79.6 ± 8.2 80.3 ± 7.5 72.9 ± 13.0 58.2 ± 16.2† 64.4 ± 15.7†
Max. P-wave duration (ms)
   Group B (n = 30) 99.0 ± 16.5 96.0 ± 18.0 96.3 ± 15.2 96.3 ± 13.3 93.3 ± 13.5
   Group L (n = 30) 99.7 ± 14.5 94.6 ± 15.0 92.7 ± 13.1 92.0 ± 14.7 90.3 ± 11.6†
Min P-wave duration (ms)
   Group B (n = 30) 42.9 ± 16.0 42.3 ± 13.8 42.7 ± 13.9 41.3 ± 12.8 42.7 ± 11.4
   Group L (n = 30) 38.3 ± 13.2 35.6 ± 12.2 33.3 ± 9.2 35.7 ± 10.4 34.3 ± 11.0
P-wave dispersion (ms)
   Group B (n = 30) 56.3 ± 19.2 53.7 ± 20.4 53.7 ± 17.7 55.7 ± 16.1 52.7 ± 17.2
   Group L (n = 30) 62.0 ± 16.7 59.0 ± 19.0 59.3 ± 11.1 56.3 ± 13.0 54.3 ± 14.5
QT interval (ms)
   Group B (n = 30) 352.7 ± 21.4 348.0 ± 20.2 339.3 ± 22.4 340.0 ± 32.1* 346.0 ± 30.1*
   Group L (n = 30) 341.0 ± 29.0 344.1±28.5 339.3±23.4 340.1±26.3 350.7±36.8
QTc interval (ms)a
   Group B (n = 30) 428.0 ± 26.0 419.0±19.1 422.7±23.5 422.1±30.6 422.8±29.3
   Group L (n = 30) 422.1 ± 19.1 421.7±25.1 418.1±23.0 422.4±24.2 420.6±32.8
QTd interval (ms)
   Group B (n = 30) 55.0 ± 10.7 49.3±13.8 49.0±11.2 53.3±15.8 55.0±11.9
   Group L (n = 30) 55.3 ± 19.7 55.0±19.6 54.6±16.7 57.0±15.5 56.0±19.5
QTcd interval (ms)b
   Group B (n = 30) 67.2 ± 16.1 64.7±17.3 71.2±36.1 65.2±35.0 69.5±17.5
   Group L (n = 30) 66.7 ± 26.7 66.0±27.8 67.7±21.0 68.0±18.0 70.3±23.0
T0: Control, T1: After the preloading, T2: 1 minute after spinal anesthesia, T3: 5 minutes after spinal anesthesia, T4: 10 
minutes after spinal anesthesia; Max: maximum; Min: minimum; HR: Heart Rate; SAP: Systolic Arterial Pressure; DAP: Diastolic 
Arterial Pressure
Values are mean ± SD.
* p < 0.05 (compared control value in Group B); † p < 0.05 (compared control value in Group L); a: QTc reﬂ ects the heart rate 
adjusted QT interval by using Bazett’s formula; b: QTcd reﬂ ects the heart rate adjusted QTd interval by using Bazett’s formula.
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When the two groups were compared with respect to 
minimum P-wave values, no statistically signiﬁ cant difference 
was seen between or within groups at any time (p > 0.05) 
(Table 3). 
Similarly, when we studied the groups’ P-wave disper-
sion values, no statistically signiﬁ cant difference was found 
between or within groups at any time (p > 0.05) (Table 3).
When we compared the groups with respect to QT values, 
we did not detect a statistically signiﬁ cant difference be-
tween Groups B and L at different measurements (p > 0.05). 
When we compared T3 and T4 times to the control value 
within Group B, we found a decrease in the QT value. This 
decrease was statistically signiﬁ cant (p < 0.05). When we 
compared the values obtained at all times in Group L to 
control values, no statistically signiﬁ cant difference existed 
in the QT value (p > 0.05) (Table 3). 
When we compared the groups with respect to QTd, QTc 
and QTcd values, we found a statistically signiﬁ cant differ-
ence both between and within groups at all times (p > 0.05) 
(Table 3). 
Ephedrine consumption was 13.3 ± 14.7 mg in Group B 
and 6.5 ± 6.2 mg in Group L. No statistically signiﬁ cant dif-
ference existed between the total ephedrine, atropine and 
metoclopramide consumption in the two groups (p > 0.05). 
Discussion
In our study we examined the effects of using bupivacaine and 
levobupivacaine in spinal anesthesia for cesarean surgeries on 
P-wave in ECG, QT, and QTc dispersion times, and we found 
no signiﬁ cant difference between the p wave, QT and QTc 
dispersions of the levobupivacaine and bupivacaine groups.
In pregnancy, a dramatic hormonal and hemodynamic 
change can be observed in the organism, which may lead 
to a proarrhythmic effect. Pregnancy may trigger the de-
velopment of new arrhythmia or exacerbate existing ones. 
Hemodynamic changes, increased cardiac output and cir-
culating blood volume cause an arrhythmogenic effect by 
increasing end diastolic volume and myocardial regression. 
In addition, elevated catecholamine levels also cause the 
development of arrhythmia. Arrhythmia and tachycardia 
are very common occurrences among pregnant women. 
Heart rate may increase by 20% during pregnancy and left 
axis deviation shows up in ECG due to the enlargement of 
the uterus. Premature atrial and ventricular beats are also 
very common 3. 
Even though spinal block may be a safe anesthesia 
technique, severe tachycardia, cardiac arrest and other 
arrhythmia are reported during spinal anesthesia practices. 
In an ASA study of closed claims project, sudden cardiac 
arrest was reported during spinal anesthesia performed on 
14 hemodynamically stable, young and healthy patients. In 
another study of 952 patients who received spinal anesthesia, 
risk factors for bradycardia and hypotension during spinal 
anesthesia were deﬁ ned as being female, a control heart 
rate below 60, use of beta-blockers, and a sensory block 
above T5 12. 
In a multiple center study conducted on over 17,000 
patients, Youngs PJ et al. 13 studied the effects of spinal 
anesthesia that cause arrhythmia. Of their subjects, 70.2% 
had tachycardia, bradycardia or arrhythmia. Most of these 
were spontaneously recovering minor arrhythmia. Sinusal 
arrhythmia was found in 30.3% of the patients, premature 
beats in 27.2%, and bradycardia in 13.8%.
The incidence of arrhythmia and hypotension among 
pregnant women who receive spinal anesthesia in cesarean 
surgeries is greater than expected. Most of these incidents 
are spontaneous and temporary. They may occur suddenly and 
require urgent treatment. In a study of 254 healthy pregnant 
women who underwent cesarean surgery, Shen CL et al. 14 
administered 10 mg bupivacaine + 0.2 mg morphine for spinal 
anesthesia, and observed 1st degree atrioventricular block in 
9 patients (3.5%), 2nd degree atrioventricular block in 9 (3.5%), 
severe bradycardia in 17 (heart rate < 50 beat.min-1) (6.7%) 
and multiple ventricular premature complexes in 3. During 
cesarean surgeries, one should take care about arrhythmia 
and handle monitoring attentively. Among our subjects, we 
observed premature ventricular beats in one pregnant woman 
in the bupivacaine group and in two women in the levobupi-
vacaine group. 
Many clinical studies have shown both bupivacaine and 
levobupivacaine to have equal effectiveness in spinal an-
esthesia over doses of 10 mg 15. Alley EA et al. 15 used 4 mg, 
8 mg and 12 mg hyperbaric bupivacaine and hyperbaric 
levobupivacaine for spinal anesthesia in 18 healthy volun-
teers and observed similar sensory and motor block levels 
in the two groups. Similarly, in our study we observed no 
signiﬁ cant difference between the sensory block levels, 
systolic blood pressure, diastolic blood pressure, heart rate 
changes, and amounts of atropine used in the two groups 
until minute 10. 
In spinal anesthesia, cardiovascular effects are related 
to the sympathetic blockage that develops with spinal an-
esthesia rather than the systemic absorption of local 
anesthetics 9. 
However, there are a limited number of studies that ex-
plore the effects of spinal anesthesia on QT and QTc intervals, 
the results of which seem to vary 10,16,17. In 20 adult males who 
did not receive premedication, Owczuk et al. 10 performed 
spinal anesthesia with 3 or 4 mL 5% hyperbaric bupivacaine 
and calculated the QTc interval from the ECG records taken at 
minutes one, three, ﬁ ve and 15, and observed a signiﬁ cantly 
prolonged QTc interval starting from minute 1 after spinal 
anesthesia induction and in later measurements. With mean 
values, they detected no signiﬁ cant difference at the onset of 
spinal block between QTc intervals and heart rate. However, 
starting from min three, a signiﬁ cant decrease was observed 
in systolic, diastolic and mean blood pressure as compared 
to control values. The QTc interval exceeded 440 msec in a 
total of eight patients, and QTc interval > 440 msec occurred 
once in two patients, twice in ﬁ ve patients, and three times 
in two patients. Prolonged QTc interval was seen at min one 
following spinal anesthesia in ﬁ ve patients, after mins three 
and ﬁ ve in three patients, and after min 15 in two patients. 
QTc interval > 500 msec occurred only in one patient, but 
severe arrhythmia or conduction did not. Ventricular ectopic 
beats were observed in one patient who had normal QTc 
interval. 
At the same time, many case studies report that spinal 
anesthesia can be used safely in pregnant women with pro-
longed QT syndrome 16-18. No complications were reported 
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during combined spinal-epidural anesthesia with 9 mg bupi-
vacaine and 100 mg lidocaine in a pregnant woman with 
asymptomatic idiopathic prolonged QT interval syndrome 
who underwent elective cesarean surgery. Kameyam et al. 19 
also emphasized that spinal anesthesia with bupivacaine 
is a safe option for patients with asymptomatic idiopathic 
prolonged QT syndrome.
Şen et al. 9 studied the effects of spinal anesthesia on 
the QTc interval of preeclamptic patients. They reported 
that even though preeclamptic patients have higher QTc 
intervals than the control group prior to spinal anesthesia, 
their interval shortens following spinal anesthesia while no 
change occurs in that of patients without preeclampsia. 
They also wrote that the sympathetic blockage effect of 
spinal anesthesia might normalize patients with prolonged 
QTc interval. 
In our study, we found that both levobupivacaine and 
bupivacaine for spinal anesthesia shortens the QT intervals 
of patients, but no statistically signiﬁ cant difference existed 
between the groups. Even though a signiﬁ cant difference did 
not exist among the subjects in the levobupivacaine group, 
the QT interval of patients who received bupivacaine for 
spinal anesthesia were signiﬁ cantly shorter than control 
values at minutes ﬁ ve and 10 after spinal anesthesia. We are 
of the opinion that this shortening in the QTc interval may 
be related to the sympathetic suppression caused by spinal 
anesthesia. Supporting ﬁ ndings were observed in a previous 
study of Owczuk et al. 20, where they had compared lumbar 
and thoracic epidural block by using isobaric bupivacaine 
and found out that QTcd was signiﬁ cantly shorter in patients 
who received thoracic epidural block, suggesting the role of 
higher symphathetic block level. 
Pregnancy may also affect QTd and QTcd times. 
Lechmanova et al. 21 compared QTds of 37 healthy pregnant 
women in their late pregnancy and postnatal days, and 
found out that parturients had signiﬁ cantly longer QTd in 
late pregnancy. In our study, we found that the QTd and 
QTcd interval of patients who received spinal anesthesia with 
levobupivacaine and bupivacaine were prolonged after spinal 
anesthesia, but a statistical difference did not exist within 
groups or in comparison with control values.
Anesthetic substances may affect P wave dispersion 
(Pwd). The general anesthetic sevoﬂ urane has been reported 
to prolong Pwd, desﬂ urane to have no effect on it, and 
propofol to shorten it 22-24. At the same time, our literature 
survey found no study that investigated the effects of local or 
spinal anesthesia on Pwd. However, in one study that evalu-
ated Pwd changes in pregnant women, Pwd was reported to 
prolong due to the shortening of minimum P wave time 25. 
In our study, we found no signiﬁ cant difference between the 
Pwd, Pmax and Pmin times of the groups following spinal 
anesthesia with either local anesthetic.
Our study has several limitations. First, P wave, QT, QTc 
dispersions were manually calculated from the ECG record. 
Even though there are many studies stating that these pa-
rameters can be measured manually with a minimal room for 
error 26,27, others mention about the reliability of this type of 
measurement 26,28. The second limitation of our study is that 
it has lasted until 10 minutes after spinal anesthesia applica-
tion and ECG records were taken with ﬁ ve-minute intervals. 
However, there are studies that show in ECG that changes 
can occur in P-wave, QT times after minute 10 10,13. We are 
of the opinion that using continuous Holter monitorization 
in addition to intermittent ECG records in future studies 
may help longer-term and more detailed identiﬁ cation of 
perioperative arrhythmia and ECG changes. Third, effects 
of ﬂ uid therapy and vasopressors on ECG records cannot be 
excluded in this study, because one has to administer these 
therapies due to ethical reasons. 
In conclusion, our double blind randomized prospective 
study which compared the electrocardiographic effects of 
spinal anesthesia by using 10 mg of bupivacaine and 10 mg of 
levobupivacaine in cesarean surgeries showed that P wave, 
QT and corrected QT dispersion values were not affected. 
For this reason, levobupivacaine and bupivacaine may be 
preferred for spinal anesthesia of the pregnant women 
with prolonged P wave and QT dispersion determined in the 
preoperative stage. 
References
1.  Hancı V, Ayoğlu H, Yurtlu S et al. - An evaluation of P-wave 
dispersion, QT, corrected QT and corrected QT dispersion 
intervals on the electrocardiograms of malnourished adults. 
Anaesth Intensive Care. 2010;38:122-127.
2.  Akçay M, Albayrak D, Akçay FK et al. - Sevoﬂ oran ile yapılan 
VİMA ve bupivakainle yapılan spinal anestezi yöntemlerinin 
QT dispersiyonuna olan etkilerinin karşılaştırılması. Türkiye 
Klinikleri J Anest Reanim. 2004;2:137-143.
3.  Emmanuel M, Kanoupakis, Panos EV - Arrhythmias and Pregnancy. 
Cardiology Department, Heraklion University Hospital, Crete, 
Greece. Hell J Cardiol. 2005;46:317-319.
4.  Wee MY - Brown H, Reynolds F - The National Institute of Clinical 
Excellence (NICE) guidelines for Caesarean sections: implications 
for the anesthetist. Int J Obstet Anesth 2005;14:147-158.
5.  Gori F, Pasqualucci A, Corradetti F, Milli M, Peduto VA - Maternal 
and neonatal outcome after Cesarean section: the impact of 
anesthesia. J Matern Fetal Neonatal Med. 2007;20:53-57. 
6.  Paech MJ - Anesthesia for Cesarean Section. In: Palmer CM, 
D’angelo R, Paech MJ, editors. Handbook of Obstetric Anesthesia 
1 st ed. Oxford: BIOS, 2002;82-113. 
7.  Zi-gang Li, Liang Zhou, and Hui-fang Tang - Effects of 
levobupivacaine and bupivacaine on rat myometrium. J Zhejiang 
Univ Sci B. 2006;7:757–62.
8.  Leone S, Di Cianni S, Casati A, Fanelli G - Pharmacology, 
toxicology, and clinical use of new long acting local anesthetics, 
ropivacaine and levobupivacaine. Acta Biomed. 2008;79:92-
105.
9.  Sen S, Ozmert G, Turan H, Caliskan E, Onbasili A, Kaya D - The 
effects of spinal anesthesia on QT interval in preeclamptic 
patients. Anesth Analg. 2006;103:1250-5.
10.  Owczuk R, Sawicka W, Wujtewicz MA, Kawecka A, Lasek J, 
Wujtewicz M - Inﬂ uence of spinal anesthesia on corrected QT 
interval. Reg Anesth Pain Med. 2005;30:548-52.
11.  Udelsmann A, Lorena SE, Grioli SU, Silva WA, Moraes AC, 
Andreollo NA - Hemodynamic effects of local anesthetics 
intoxication: experimental study in swine with levobupivacaine 
and bupivacaine. Acta Cir Bras. 2008;23:55-64. 
12.  Benumof JL, Saidman LJ - Anesthesia and perioperative 
complications. Second edition. 1999;50-63.
13.  Youngs PJ, Littleford J - Arrhythmias during spinal anesthesia. 
Can J Anaesth. 2000;47:385-390.
14.  Shen CL, Ho YY, Hung YC, Chen PL - Arrhythmias during spinal 
anesthesia for Cesarean section. Can J Anaesth. 2000;47:393-
397.
208 Y. Deniz et al.
15.  Alley EA, Kopacz DJ, McDonald SB, Liu SS - Hyperbaric spinal 
levobupivacaine: a comparison to racemic bupivacaine in 
volunteers. Anesth Analg. 2002;94:188-193.
16.  Pedroviejo Saez V, Lasa Unzue C - Intradural anesthesia for 
emergency cesarean section in a woman with congenital long 
QT syndrome. Rev Esp Anestesiol Reanim. 2011;58:189-191.
17.  Palkar NV, Crawford MW - Spinal anaesthesia in prolonged Q-T 
interval syndrome. Br J Anaesth. 1986;58:575-576.
18.  Al-Refai A, Gunka V, Douglas J - Spinal anesthesia for Cesarean 
section in a parturient with long QT syndrome. Can J Anaesth. 
2004;51:993-996.
19.  Kameyama E, Ito Y, Ito J et al - Anesthetic management of 
caesarean section in a patient with asymptomatic idiopathic 
prolonged QT interval syndrome. Eur J Anaesthesiol. 
2004;21:566-570.
20.  Owczuk R, Steffek M, Wujtewicz MA - Inﬂ uence of reversible 
adrenergic blockade of the heart obtained through thoracic 
epidural anaesthesia on cardiac repolarisation effects on cardiac 
repolarisation of reversible adrenergic blockade through thoracic 
epidural anaesthesia. Clin Exp Pharmacol Physiol. 2009 [in press]. 
Available at: [http://www.biomedsearch.com/nih/Inﬂ uence-
reversible-adrenergic-blockade-heart/19298541.html]
21.  Lechmanová M, Kittnar O, Mlcek M et al. - QT dispersion and 
T-loop morphology in late pregnancy and after delivery. Physiol 
Res. 2002;51:121-129.
22.  Kazanci D, Unver S, Karadeniz U et al. - A comparison of the 
effects of desﬂ urane, sevoﬂ urane and propofol on QT, QTc, and 
P dispersion on ECG. Ann Card Anaesth. 2009;12:107-112.
23.  Owczuk R, Wujtewicz MA, Sawicka W et al - Effect of anaesthetic 
agents on p-wave dispersion on the electrocardiogram: 
comparison of propofol and desﬂ urane. Clin Exp Pharmacol 
Physiol. 2008;35:1071-1076.
24.  Hanci V, Aydin M, Yurtlu BS et al. - Anesthesia induction with 
sevoﬂ urane and propofol: evaluation of P-wave dispersion, 
QT and corrected QT intervals. Kaohsiung J Med Sci. 
2010;26(9):470-477.
25.  Ozmen N, Cebeci BS, Yiginer O, Muhcu M, Kardesoglu E, 
Dincturk M - P-wave dispersion is increased in pregnancy due 
to shortening of minimum duration of P: does this have clinical 
signiﬁ cance. J Int Med Res. 2006;34:468-474.
26.  Dilaveris PE, Gialafos JE - P-wave dispersion: a novel predictor 
of paroxysmal atrial ﬁ brillation. Ann Noninvasive Electrocardiol. 
2001;6:159-165.
27.  Ciaroni S, Cuenoud L, Bloch A - Clinical study to investigate 
the predictive parameters for the onset of atrial ﬁ brillation in 
patients with essential hypertension. Am Heart J. 2000;139:814-
819.
28.  Dilaveris PE, Gialafos JE - P-wave duration and dispersion analysis: 
methodological considerations. Circulation. 2001;29:E111-1.
